Advisory Board

The Advisory Board for the Massachusetts General Hospital Center for Global Health engages community, former government, global health, and business leaders who lend their expertise to hospital leadership on issues facing Mass General and the global healthcare industry, as a whole.

  • Alan Batkin
    Chair

    From March 2007 TO December 2012, Alan R. Batkin was Vice Chairman of Eton Park Capital Management, L.P., a global, multi-disciplinary investment organization with over $11 billion of capital. Prior to joining Eton Park, he was, from 1990 to 2007, Vice Chairman of Kissinger Associates, Inc., a geopolitical consulting firm which advises multi-national companies on business and political issues around the world. From 1972 to 1990, Mr. Batkin was an investment banker at Lehman Brothers, Inc., where he was a Managing Director from 1976 to 1990 in the corporate finance area. He was at Coopers & Lybrand from 1968 to 1972.

    From March 2007 TO December 2012, Alan R. Batkin was Vice Chairman of Eton Park Capital Management, L.P., a global, multi-disciplinary investment organization with over $11 billion of capital. Prior to joining Eton Park, he was, from 1990 to 2007, Vice Chairman of Kissinger Associates, Inc., a geopolitical consulting firm which advises multi-national companies on business and political issues around the world. From 1972 to 1990, Mr. Batkin was an investment banker at Lehman Brothers, Inc., where he was a Managing Director from 1976 to 1990 in the corporate finance area. He was at Coopers & Lybrand from 1968 to 1972.

    Mr. Batkin is a director of three public companies (Omnicom Group, Inc.; Hasbro, Inc. and Cantel Medical Corp.). Mr. Batkin is Chairman Emeritus of the International Rescue Committee (after having served as Co-Chairman of the Board from 2004-2010).  He is a Trustee of The Brookings Institution AND of the NYC Police Foundation. He is a member of The Trilateral Commission, the Council on Foreign Relations and the Inter-American Dialogue. Until its recent merger, Mr. Batkin was Chairman of the Board of Continuum Hospice Care - one of the largest hospices in New York City. He is a trustee of Continuum Health Partners and its two major hospitals (Beth Israel Medical Center and St. Luke’s-Roosevelt Hospital Center). He is a member of the Board of Overseers of the Mailman School of Public Health of Columbia University and a Board member of Millennium Promise. He received a B.S. degree from the University of Rochester in 1966 and an M.B.A. from New York University in 1968.

  • Uche Amazigo, PhD

    Uche Amazigo is an international Public Health specialist with broad and diverse expertise in Policy & Strategy Development, Community-Driven Health Interventions and Research and Public-Private Partnership.

    Uche Amazigo is an international Public Health specialist with broad and diverse expertise in Policy & Strategy Development, Community-Driven Health Interventions and Research and Public-Private Partnership.

    Integrating science and social science, she has a Doctorate degree in Biology and Medical Parasitology from the University of Vienna, Austria and a post-graduate diploma in Tropical Medicine & Parasitology from the Bernhard-Nocht Institute of Tropical Medicine (Hamburg). She is also a Takemi Fellow in International Health from the School of Public Health, Harvard University, USA. Multilingual and multicultural, her background, training and experience has provided an excellent foundation to allow her to assume a leadership role in global public health.

    Following a period as Science Officer at the African Programme for Onchocerciasis Control (APOC) – a UN-based multidisciplinary agency partnership, which she helped to create in the mid-1990s, Amazigo served as the programme’s Director from 2005-2011. APOC’s unique and highly-successful operations are based almost entirely on the results of her research and use of the innovative Community-Directed Intervention (CDI), which empowers rural populations to take an active and decisive part in decision-making concerning their health. The CDI mechanism is being widely embraced and has been adopted by Ministries of Health and being integrated into the curriculum of 36 medical and nursing schools in 12 countries in Africa. Equally adept in a remote rural village, during her tenure at APOC she coordinated APOC’s 108 Community-Directed Treatment with ivermectin projects in 16 African countries, undertaking essential high-level political liaison, advocacy, fundraising, coordination, network creation, capacity building and scientific oversight roles.

    Amazigo initially joined the World Health Organization (WHO) in 1996 and up until 2005 was responsible for designing APOC’s control strategy and had oversight responsibility for the normative and operational work of the Sustainable Drug Distribution (SDD) unit of APOC. She worked closely with national control programs of 19 member countries in stable and post-conflict environments. In 2001, she became Chief of APOC’s Sustainable Drug Distribution unit, charged with strengthening community ownership of ivermectin distribution and addressing the challenges of sustainability of control.

    Prior to joining the World Health Organization, Amazigo was a Senior Lecturer and Researcher at the University of Nigeria, Nsukka from 1978. Her early insights into, and interest in gender and Onchocerciasis (River Blindness), which stem from her early life in her native Nigeria, led to her pioneering research that formed the scientific basis for establishing the African Programme for Onchocerciasis Control (APOC) which extended control of River Blindness to 19 countries in sub-Saharan Africa. Her research work on adolescent reproductive health also led to the production of ‘Broken Wings'- a UNFPA-sponsored film on Teenage Pregnancy for the World Conference on Women in Beijing, China (1995).

    Amazigo has held strategic management positions at international and regional levels. She has worked closely with African Governments and NGOs in 19 African countries for over 15 years, engaging and coordinating the efforts of over 120,000 communities, 14 civil societies, and 20 donors, the CDI approach to bring multiple health interventions to remote, rural areas which were hitherto beyond the reach of health care services - in both stable and conflict-ravaged countries. She has over 50 scientific and social science publications in peer reviewed journals. Her work on River Blindness helped to dramatically change international policy and the way in which the disease was viewed by the world, and the results are reflected in the recent shift from a control goal to one of disease elimination. Her vision is to continue to empower communities to contribute to health initiatives and strengthen health systems in sub-Saharan Africa. Amazigo is married with two children. She retired from WHO in 2011 and is currently a Freelance Consultant based in Nigeria - a tireless advocate for improvements in the health of all her fellow Africans and, most especially, remains passionately committed to achieving the goal of eliminating the scourge of River Blindness from the continent.

  • Nita Mukesh Ambani

    Nita Ambani is an educationist and a philanthropist. She is Founder and Chairperson of Reliance Foundation, which has touched the lives of over four million people across India through its work in rural transformation, education, health, urban renewal, arts, culture and heritage, environmental protection and disaster relief. She is the President of Sir H.N. Reliance Foundation Hospital and Research Centre, a newly built state-of-the-art hospital in Mumbai, with the vision of providing affordable international quality healthcare for all.

    Nita Ambani is an educationist and a philanthropist. She is Founder and Chairperson of Reliance Foundation, which has touched the lives of over four million people across India through its work in rural transformation, education, health, urban renewal, arts, culture and heritage, environmental protection and disaster relief. She is the President of Sir H.N. Reliance Foundation Hospital and Research Centre, a newly built state-of-the-art hospital in Mumbai, with the vision of providing affordable international quality healthcare for all.

    Reliance Foundation’s health outreach program provides free and subsidized primary and preventive healthcare to people in the vicinity of this hospital and it has already served over 3,50,000 beneficiaries. Ambani is the Founder and Chairperson of Dhirubhai Ambani International School, India’s No. 1 International School. She is on the Board of East India Hotels Ltd, which runs the Oberoi chain of hotels and manages the Trident properties in India. She is on the Board of Directors of Reliance Industries Limited, India’s largest private sector company and a Fortune Global 500 company. Ambani is the driving force behind the Indian Premier League cricket team Mumbai Indians and the recently launched Indian Super League that is set to revolutionize footballing in India. She is also strongly committed to the development of these and many other sports at the grassroots level. She is married to Mukesh Ambani, Chairman and Managing Director of Reliance Industries Limited.

  • Brett M. Berry

    Brett Berry is the founder and Managing Director of Bacca Capital, LCC, an early-stage venture capital enterprise with concerns currently in the United States and India.  Prior to Bacca Capital, Mr. Berry was President/CEO of The Fresh Market (NASDAQ: TFM), where he was employed from 1998 to 2009.   Mr. Berry currently sits on the Board of Directors for The Fresh Market as its Vice Chairman.  Before his time in high-end grocery retail, Mr. Berry consulted to national and international telecommunications companies while he worked at Mercer Management Consulting (now Oliver Wyman Consulting).

    Brett Berry is the founder and Managing Director of Bacca Capital, LCC, an early-stage venture capital enterprise with concerns currently in the United States and India.  Prior to Bacca Capital, Mr. Berry was President/CEO of The Fresh Market (NASDAQ: TFM), where he was employed from 1998 to 2009.   Mr. Berry currently sits on the Board of Directors for The Fresh Market as its Vice Chairman.  Before his time in high-end grocery retail, Mr. Berry consulted to national and international telecommunications companies while he worked at Mercer Management Consulting (now Oliver Wyman Consulting).

    Mr. Berry’s philanthropic endeavors are channeled through his family foundation, The Bacca Foundation.  In addition to its work with the Center for Global Health at Massachusetts General Hospital, The Bacca Foundation supports early detection of cancer research at the Canary Center at Stanford University.  The Bacca Foundation is also focused on transformative secondary education through its involvement with Duke University and Davidson College.   Representing The Bacca Foundation and in addition to serving on the Advisory Board at the Center for Global Health at MGH, Mr. Berry sits on the Board of Visitors of Davidson College.  He also serves on the board of eTown, a nationally syndicated radio broadcast building community through music.

    Mr. Berry received an A.B. in English Literature from Davidson College, a J.D. from the University of North Carolina, and an M.B.A. from the Wharton School at the University of Pennsylvania.

  • Gary M. Cohen

    Gary Cohen is executive vice president of Becton, Dickinson & Co. (BD), a global medical technology company with over $7 billion revenues and 29,000 employees in 50 countries.  He is board chair of the CDC Foundation and a board director of the Perrigo Company, the US Fund for UNICEF, GBCHealth and the Accordia Global Health Foundation.  He also serves as a Commissioner for the UN Commission on Life Saving Commodities for Women and Children, chair of the CDC/Corporate Roundtable on Global Health Threats and an advisor to the Clinton Global Initiative. 

    Gary Cohen is executive vice president of Becton, Dickinson & Co. (BD), a global medical technology company with over $7 billion revenues and 29,000 employees in 50 countries.  He is board chair of the CDC Foundation and a board director of the Perrigo Company, the US Fund for UNICEF, GBCHealth and the Accordia Global Health Foundation.  He also serves as a Commissioner for the UN Commission on Life Saving Commodities for Women and Children, chair of the CDC/Corporate Roundtable on Global Health Threats and an advisor to the Clinton Global Initiative. 

    Gary and the BD team are extensively engaged in collaborations across the public, private and NGO sectors to address health needs in developing and emerging countries.  He has served as an advocate, speaker and expert panelist on global health, child immunization, HIV/AIDS and health system strengthening, in venues including the United Nations, World Bank, World Economic Forum (Davos), US Department of State and Council on Foreign Relations. Gary founded Together for Girls, a new partnership to address the human rights and public health impacts of sexual violence against girls, comprised of UNICEF, UNAIDS, UNFPA, UN Women, the World Health Organization, the CDC, the US Department of State - Office of the US Global AIDS Coordinator (PEPFAR) and Office of Global Women’s Issues (GWI), the Nduna Foundation, BD and other partners. 

    Gary has been honored for his humanitarian work by MESAB (Medical Education for South African Blacks), B’nai B’rith International, the US Fund for UNICEF, the Nyumbani Home (an orphanage in Kenya for HIV positive children) and the Dikembe Mutombo Foundation.  He earned a BA from Rutgers College and a MBA from the Rutgers Graduate School of Management, and previously served on the university’s Board of Trustees.

  • Susan Dentzer

    Susan Dentzer is a Senior Policy Adviser at the Robert Wood Johnson Foundation.  She is the former editor-in-chief of Health Affairs, the nation's leading peer-reviewed journal focused on the intersection of health, health care and health policy in the United States and internationally. One of the nation's most respected health and health policy journalists, Dentzer is an on-air analyst on health issues with the PBS NewsHour, and a frequent guest and commentator on such National Public Radio shows as This American Life and The Diane Rehm Show. Dentzer is also an elected member of the Institute of Medicine and the Council on Foreign Relations.

    Susan Dentzer is a Senior Policy Adviser at the Robert Wood Johnson Foundation.  She is the former editor-in-chief of Health Affairs, the nation's leading peer-reviewed journal focused on the intersection of health, health care and health policy in the United States and internationally. One of the nation's most respected health and health policy journalists, Dentzer is an on-air analyst on health issues with the PBS NewsHour, and a frequent guest and commentator on such National Public Radio shows as This American Life and The Diane Rehm Show. Dentzer is also an elected member of the Institute of Medicine and the Council on Foreign Relations.

    Prior to Health Affairs, Ms. Dentzer was on-air Health Correspondent at the PBS NewsHour, chief economics correspondent and economics columnist for U.S. News & World Report and a senior writer covering business and economic news at Newsweek. Ms. Dentzer's other work in television has included appearances as a regular analyst or commentator on CNN and The McLaughlin Group. Her writing has also earned her several fellowships, including a Nieman Fellowship at Harvard University. She is an elected member of the National Academy of Social Insurance, a fellow of the Hastings Center, chair of the Board of Directors of the Global Health Council, the largest membership organization of groups involved in global health, and a member of the Board of Directors of the International Rescue Committee. She also chairs the IRC board's Health Committee. Ms. Dentzer is a graduate of Dartmouth, a holder of an honorary master of arts from the institution, a trustee emerita and chaired the Dartmouth Board of Trustees from 2001 to 2004. She currently serves as a member of the Board of Overseers of Dartmouth Medical School.

  • France Chr├ętien Desmarais

    After studies in Law and Economics at the University of Ottawa, France Chrétien Desmarais devoted her time to raising her four children, while continuing to be involved in numerous companies and charitable organizations. In addition to her role as co-owner and Chairman of Maxi-Crisp Canada Inc., she also serves as a member of the Board of Directors of Lombard Odier Darier Hentsch (Canada) Inc., Vice-Chair and founding member of the Guy Laliberté Foundation, and Vice-Chair and founding member of the ONE DROP Foundation.

    After studies in Law and Economics at the University of Ottawa, France Chrétien Desmarais devoted her time to raising her four children, while continuing to be involved in numerous companies and charitable organizations. In addition to her role as co-owner and Chairman of Maxi-Crisp Canada Inc., she also serves as a member of the Board of Directors of Lombard Odier Darier Hentsch (Canada) Inc., Vice-Chair and founding member of the Guy Laliberté Foundation, and Vice-Chair and founding member of the ONE DROP Foundation.

    Desmarais is a member of the Executive Committee of the Montreal Heart Institute Foundation, a member of the Board of Directors of “Partnership for a Drug-Free Canada,” and Director of the McGill University International Centre for Youth Gambling Problems and High-Risk Behaviors Board. She is also a member of the Board of Directors of the Fondation Québécoise du Patrimoine, Governor of the Lester B. Pearson College of the Pacific, and a member of the Brown University Advisory Council on Asia. She also serves as Director of the IMusici Board of Directors.

    Previously, Desmarais served as a member of the Board of Directors of the Vancouver 2010 Bid Corporation for the 2010 Olympic and Paralympic Winter Games, member of the Board of Directors of the Vancouver Organizing Committee for the 2010 Olympic and Paralympic Winter Games (VANOC), and was the founding Chairman of the Canadian Olympic Foundation. From 2001 to 2009, she served as Chairman of the Montreal Heart Institute Foundation Board of Directors. In the previous decade, Desmarais was a member of the Board of Directors of the Selwyn House School, a member of the council for Canadian Unity, member of the education committee of the American Society and Writers Development Trust, and Governor of the Montreal Clinical Research Institute.

    France Chrétien Desmarais was born in Shawinigan and now lives in Montreal. She is married to André Desmarais, President and Co-CEO of Power Corporation of Canada.

  • Emmanuel d’Harcourt, MD, MPH

    Emmanuel d’Harcourt is a pediatrician and public health physician who has worked for the Peace Corps, the Pasteur Institute, and for 17 years with the International Rescue Committee, most recently as the Senior Health Director.

    Emmanuel d’Harcourt is a pediatrician and public health physician who has worked for the Peace Corps, the Pasteur Institute, and for 17 years with the International Rescue Committee, most recently as the Senior Health Director.

    He has worked as a clinician, researcher, outbreak responder, and manager.  He has lived in Senegal, Bolivia, and Rwanda, and worked in Africa and Asia, focusing on child health, reproductive health, and health systems in communities affected by conflict.  He received his MD from Johns Hopkins University and his MPH from Harvard University, and completed a pediatric residency at the Children's Hospital of Philadelphia.

  • The Honorable William H. Frist, MD

    Senator Bill Frist is a nationally recognized heart and lung transplant surgeon and former U.S. Senate Majority Leader. Uniquely qualified to discuss the challenges and solutions in health care policy, Senator Frist is consistently recognized among the most influential leaders in American healthcare and is one of only two individuals to rank in the top ten of each of the five inaugural Modern Healthcare Magazine annual surveys of the most powerful people in healthcare in the United States.

    Senator Bill Frist is a nationally recognized heart and lung transplant surgeon and former U.S. Senate Majority Leader. Uniquely qualified to discuss the challenges and solutions in health care policy, Senator Frist is consistently recognized among the most influential leaders in American healthcare and is one of only two individuals to rank in the top ten of each of the five inaugural Modern Healthcare Magazine annual surveys of the most powerful people in healthcare in the United States.

    Senator Frist majored in health policy at Princeton University’s Woodrow Wilson School of Public and International Affairs before graduating with honors from Harvard Medical School and completing surgical training at Massachusetts General Hospital and Stanford.

    As the founder and Director of the Vanderbilt Multi-Organ Transplant Center, he has performed over 150 heart and lung transplants and authored over 100 peer-reviewed medical articles and chapters, over 400 newspaper articles, and seven books on topics such as bioterrorism, transplantation, and leadership. He is board certified in both general and heart surgery. Dr. Frist represented Tennessee in the U.S. Senate for 12 years where he served on both Health and Finance committees responsible for writing health legislation. He was elected Majority Leader of the Senate, having served fewer total years in Congress than any person chosen to lead that body in history, and his leadership was instrumental in passage of prescription drug legislation and funding to fight HIV/AIDS at home and around the world.

    Frist is chair of Save the Children’s “Newborn and Child Survival” campaign and the Nashville-based Hope Through Healing Hands. His current board service includes the Clinton Bush Haiti Fund, First Lady Michelle Obama’s “Partnership for a Healthier America” campaign to eliminate childhood obesity within a generation, the Bipartisan Policy Center, the Kaiser Family Foundation, ONE Vote 2010, the Smithsonian Museum of Natural History, the Center for Strategic and International Studies, Harvard Medical School Board of Fellows, and the Advisory Committees for Global Health at Duke and Harvard. 

    Senator Frist was the 2007-2008 Frederick H. Schultz Professor of International Economic Policy at Princeton University’s Woodrow Wilson School of Public and International Affairs, and the 2010 University Distinguished Professor of Business and Medicine at Vanderbilt University. He is a partner in the private equity firm of Cressey and Company. Dr. Frist is married, and has three sons, and lives in Nashville, Tennessee.

  • Adrian Gore

    Adrian Gore is a leading South African businessman and entrepreneur who founded the global diversified financial services group, Discovery, in 1992. He is an actuary by qualification, and has been admitted as a Fellow of the Actuarial Society of South Africa, a Fellow of the Faculty of Actuaries (Edinburgh), an Associate of the Society of Actuaries (Chicago), and is also a member of the American Academy of Actuaries.

    Adrian Gore is a leading South African businessman and entrepreneur who founded the global diversified financial services group, Discovery, in 1992. He is an actuary by qualification, and has been admitted as a Fellow of the Actuarial Society of South Africa, a Fellow of the Faculty of Actuaries (Edinburgh), an Associate of the Society of Actuaries (Chicago), and is also a member of the American Academy of Actuaries.

    He currently serves as CEO of the Discovery Group, which generates total income flows in excess of R40bn across South Africa, the United Kingdom, and the United States, and which is in the process of entering China. The group covers approximately 4.3 million customers globally. 

    Mr. Gore has been recognised internationally as a thought leader in the areas of healthcare and wellness, having authored papers on modelling healthcare reform, as well as on healthcare financing, delivery and structuring. He has presented papers on both healthcare and wellness in a number of global forums, including to the South African Actuarial Society and the Healthcare Section of the International Actuarial Association, as well as to think tanks and governmental agencies in the United States, including The National Institute for Healthcare Management in Washington, D.C. Mr. Gore is a delegate of the World Economic Forum, and in 2009, was appointed to the World Economic Forum Global Health Advisory Board, a component of the World Economic Forum that is committed to improving the state of global healthcare; the twelve-member board includes representation from leading multi-national organisations, academic institutions, and the World Health Organisation.

    Mr. Gore is committed to business and societal development, and in this regard, serves as Chairman of Endeavor South Africa (a global non-profit organisation focused on identifying and developing entrepreneurial talent), is a former board member of the International Marketing Council of South Africa (the custodian of Brand South Africa), and is a former board member of The Ethics Institute of South Africa.  He has been recognised as South Africa’s Leading Entrepreneur by Ernst&Young (1998), was nominated as South Africa’s Leading CEO by a peer group of South African CEOs in the annual MoneyWeb CEOs CEO of the Year Awards (2004, finalist 2006), as well as winning the South African Leading Managers Award, an initiative of the Corporate Research Foundation and Business Report (2006). Mr. Gore also won the Investec Award for Considerable Contribution in a Career/Profession (2008). In November 2010, Mr. Gore was chosen as the Sunday Times Business Leader of the Year. He is married to Lauren, has two daughters and a son. He is an avid runner.

  • Thomas L. Harrison, LH.D.

    Thomas Harrison is Chairman of Diversified Agency Services (DAS), the world’s largest group of marketing services companies. A division of the Omnicom Group, DAS provides a broad range of marketing communications services including public relations, crisis management, branding, sales promotion, customer relationship management and specialty communications including health care advertising. With over 5000 worldwide clients, the DAS division has annual revenues of almost $6.0 billion and is the largest unit within Omnicom. Diversified Agency Services is the world’s largest holding company of specialty marketing agencies.

    Thomas Harrison is Chairman of Diversified Agency Services (DAS), the world’s largest group of marketing services companies. A division of the Omnicom Group, DAS provides a broad range of marketing communications services including public relations, crisis management, branding, sales promotion, customer relationship management and specialty communications including health care advertising. With over 5000 worldwide clients, the DAS division has annual revenues of almost $6.0 billion and is the largest unit within Omnicom. Diversified Agency Services is the world’s largest holding company of specialty marketing agencies.

    Under Harrison’s watch, the DAS division has more than quadrupled in size and now accounts for well over 50% of the total revenues of Omnicom. He has acquired and heads a list of companies that are the most influential in their disciplines particularly in public relations, relationship marketing, branding, healthcare communications and digital communications. He has developed not only the largest and most innovative and relevant group of specialized agencies, but the most diverse as well.

    Harrison’s multi-faceted career brought him to Omnicom in 1992 when the firm he co-founded, Harrison & Star Business Group, the most successful and rapidly growing agency in the healthcare industry at the time, was acquired. Harrison served as Chairman of the Harrison & Star Group and Chairman of Diversified Healthcare Communications, a group of eight healthcare agencies within Omnicom, until his appointment as President of DAS in 1997. He was named Chairman and Chief Executive of DAS in 1998.

    With an advanced degree in cell biology and physiology, Harrison began his business career at Pfizer Laboratories as a professional sales representative and later left Pfizer as marketing director. He then joined a mid-sized healthcare advertising agency for six years before starting his own company, The Harrison & Star Business Group. While at the helm he started two healthcare advertising agencies, a medical education company, a direct-to-consumer healthcare company and a medical PR group as well as acquiring a managed care consultancy.

    Harrison serves on a number of prestigious boards. He is a member of the Executive Committee of the Montefiore Hospital and is Fellow of the New York Academy of Medicine.  He has served as a board member of the New York Chapter of the Arthritis Foundation.  Harrison is board member for ePocrates, a publicly traded healthcare information company, The Morgans Hotel Group, and is a governor of The New York Academy of Sciences where he sits on the Sackler Global Nutrition Committee, a long-time passion of Harrison’s. He was President of a local Westchester County School Board and Chairman and Founder of the not-for-profit education foundation in that Westchester School District. He has served as co-chairman of the New York Chapter of the U.S. Olympic Committee and raised substantial funding to support U.S. Olympic Athletes. He has been honored by Long Island College Hospital, The Children’s Hospital at Montefiore, The Lymphoma Research Foundation, New York City’s Health and Hospital Corporation, Mt. St. Vincent’s College and will be honored this year by the New York Academy of Medicine for his philanthropic work. A frequent speaker at business forums and at universities across the U.S. on the subject of entrepreneurialism, lectures on business strategies, the “Secrets to Success” and corporate leadership in the economic upturn. He has spoken at West Virginia University where he did his graduate research and where Harrison was recognized with the 2006 Distinguished Alumni Award and where Harrison received an Honorary Doctorate in 2007, the highest honor an American University grants to an individual. He was keynote speaker at The McGraw Hill Medical Publishers Annual Awards program, at a recent Management Conference of Healthcare Communications specialists, at the 2007 Direct Marketing Association Non-Profit Federation Summit, at the Utah Technology Council Annual Members Board Meeting and has talked to agency CEO’s at an advertising industry forum about the future of advertising agencies, marketing services and ideation. 

    Harrison is the author of INSTINCT: Tapping Your Entrepreneurial DNA to Achieve Your Business Goals published by Warner Business Books. Harrison has appeared on CNBC, CNNI, Bloomberg and Forbes.com discussing his book. He can be found on the Enterprise Leadership podcast as well as Forbes, Bloomberg, recently on American Management Association and other podcasts. Harrison also lectures at Business Schools and Schools of Entrepreneurialism on topics discussed in INSTINCT.

    Harrison is a member of the New York University Campaign Steering Committee, is immediate past Chairman of the Dean’s Council at The Steinhardt School of Education at NYU and is a Trustee at The Kent School, a New England Preparatory School.

  • Nicholas Hellmann, MD

    Dr. Nick Hellmann is the Executive Vice President of Medical & Scientific Affairs at the Elizabeth Glaser Pediatric AIDS Foundation, responsible for strategic oversight and direction of the Foundation’s research initiatives and medical programs at over 5,000 foundation-supported sites in 17 countries across the globe. Prior to joining the Glaser Foundation, Dr. Hellmann led the HIV/AIDS and Tuberculosis and Reproductive Health program at the Bill and Melinda Gates Foundation.

    Dr. Nick Hellmann is the Executive Vice President of Medical & Scientific Affairs at the Elizabeth Glaser Pediatric AIDS Foundation, responsible for strategic oversight and direction of the Foundation’s research initiatives and medical programs at over 5,000 foundation-supported sites in 17 countries across the globe. Prior to joining the Glaser Foundation, Dr. Hellmann led the HIV/AIDS and Tuberculosis and Reproductive Health program at the Bill and Melinda Gates Foundation.

    Since 1982, Dr Hellmann’s career has primarily focused on clinical and research aspects of HIV/AIDS. After graduating from the University of Kentucky College of Medicine in 1982, Dr. Hellmann worked for nine years at the University of California, San Francisco, where he completed his internal medicine residency and infectious diseases fellowship training. Dr. Hellmann then served on the medical faculty while studying heterosexual transmission of HIV in East Africa. In addition to his background in global health, Dr Hellmann has extensive experience in the pharmaceutical and biotechnology sectors, where he worked for 12 years at Bristol-Myers Squibb, Gilead Sciences, ViroLogic, and Roche Molecular Systems to develop drugs and diagnostic technologies for the treatment and management of HIV/AIDS and other serious infectious diseases.

  • Lord Mark Malloch Brown

    Lord Mark Malloch Brown is Chairman of FTI Global Affairs focusing on advising corporatations on the risks and opportunities associated with international development, particularly in emerging markets. Formerly he was Minister of State in the Foreign Office, covering Africa and Asia, and was a member of Gordon Brown’s cabinet.  He had previously served as Deputy Secretary-General and Chief of Staff of the UN under Kofi Annan. 

    Lord Mark Malloch Brown is Chairman of FTI Global Affairs focusing on advising corporatations on the risks and opportunities associated with international development, particularly in emerging markets. Formerly he was Minister of State in the Foreign Office, covering Africa and Asia, and was a member of Gordon Brown’s cabinet.  He had previously served as Deputy Secretary-General and Chief of Staff of the UN under Kofi Annan. 

    For six years he was Administrator of the United Nations Development Programme, leading the UN’s development efforts around the world. Other positions have included vice-chairman of George Soros’s Investment Funds, as well as his Open Society Institute, a Vice-President at the World Bank and the lead international partner in a political consulting firm. He began his career as a journalist on The Economist. He is chair of the Royal Africa Society and on a number of non-profit and advisory boards.  He is a member of the House of Lords and was knighted in 2007

  • Joe Mandato, PhD

    Joe Mandato is a managing director and general partner of DeNovo Ventures, a venture firm investing in the life sciences. During his tenure, he led investments in 10 medical device companies spanning a broad range of medical specialties. Prior to DeNovo, he was an active entrepreneur and led several health care companies.

    Joe Mandato is a managing director and general partner of DeNovo Ventures, a venture firm investing in the life sciences. During his tenure, he led investments in 10 medical device companies spanning a broad range of medical specialties. Prior to DeNovo, he was an active entrepreneur and led several health care companies.

    He served as Chairman of Confer Software, a developer of software used to create efficiencies and streamline processes in healthcare. He advised the founders and was appointed to the board of Align Technology, the developer of the Invisalign clear orthodontic appliance and was a first round investor in Intuitive Surgical, the pioneer of robotic surgery. Earlier, he served as President/CEO of Origin Medsystems, a developer of minimally invasive surgical devices for use in general, cardio-thoracic, and ob-gyn surgery, where he also co-founded and served as CEO of Gynecare, a women’s health spin-out of Origin. Origin was acquired by Guidant Corporation, where Mandato served as a vice-president and member of the founding management committee and CEO of two of its five operating units, Origin and Heart Rhythm Technology. Subsequent to his tenure at Guidant, he served as an Entrepreneur-in-Residence at Mayfield Fund, a venture capital firm. Earlier in his career, he was CEO of Ioptex Research, a developer of intraocular lenses used in cataract surgery, which was acquired by Smith & Nephew PLC. He joined Ioptex from Cilco AG in Zug, Switzerland, the Europe, Middle East, Africa headquarters of a unit of Rorer Group where he served as CEO. He began his career in healthcare as a Captain in the U.S. Army Medical Service Corps. He serves on the boards of Embrace Global and Save the Children. He received his doctorate degree in management from Case Western Reserve University, and serves on its Board of Trustees. His research focused on the evolving role of boards in ensuring effective governance. He also is a Lecturer at Stanford University, where he co-teaches the class Medical Device Innovation. Joe is a 2012 Fellow of the Advanced Leadership Initiative at Harvard University. ALI is a joint program of the Harvard Professional Schools targeting leaders from the public and private sector looking to re-connect with the academy to help identify and deploy solutions to critical social problems.

  • Lisa Mooney

    Lisa Mooney serves as a member of the Mass General Hospital for Children's Advisory Board as well as a member of MGH Presidents Council.  She is also a member of the Board of Directors of Facing History and Ourselves as well as their NE Advisory Board.  Lisa is also a member of the Board of Trustees of Newton Country Day School.

  • Peter Mugyenyi, MD

    Dr. Peter Mugyenyi is the Founder and Director of the Joint Clinical Research Centre in Kampala, Uganda, and a leader in the HIV/AIDS research community. A pediatrician by training, Dr. Mugyenyi has worked in the medical field for decades and on HIV/AIDS since the epidemic in Uganda began in the late 1980s.

    Dr. Peter Mugyenyi is the Founder and Director of the Joint Clinical Research Centre in Kampala, Uganda, and a leader in the HIV/AIDS research community. A pediatrician by training, Dr. Mugyenyi has worked in the medical field for decades and on HIV/AIDS since the epidemic in Uganda began in the late 1980s.

    He has served as visiting professor, chairperson, and board member at a number of universities and organizations in the U.S., Europe, and Africa, including the Institute of Medicine of the National Academies in Washington, DC. CNN Video: Uganda's Fight Against HIV

  • James F. Orr, III

    Jim Orr has been the chairman of the board of trustees of the Rockefeller Foundation since 2000. The Rockefeller Foundation, one of the nation’s largest private foundations, is centered on improving opportunities for poor people in targeted regions of the world. Mr. Orr established LandingPoint Capital, a private investment firm in 2002. He was the former chairman and CEO of United Asset Management Company from 2000 to 2001. 

    Jim Orr has been the chairman of the board of trustees of the Rockefeller Foundation since 2000. The Rockefeller Foundation, one of the nation’s largest private foundations, is centered on improving opportunities for poor people in targeted regions of the world. Mr. Orr established LandingPoint Capital, a private investment firm in 2002. He was the former chairman and CEO of United Asset Management Company from 2000 to 2001. 

    He was chairman and CEO of UNUM Provident Corporation, and insurance provider in 1999 and was chairman and CEO of its predecessor, UNUM Corporation from 1987 to 1999.  From 1975 to 1986, he was executive vice president and treasurer of Connecticut Bank & Trust Company. Previously, he was president of Cardinal Management Company, an investment firm in Boston. Mr. Orr received his bachelor’s degree from Villanova University in 1965 and his M.B.A. from Boston University in 1970.

  • Steven C. Phillips, MD, MPH

    Dr. Steven Phillips is the Medical Director, Global Issues and Projects, Exxon Mobil Corporation, where his responsibilities include overseeing the Corporation's "outside-the-fenceline" community and public health programs throughout its global operations. In this capacity, he has worked closely with governments, NGO's, U.N. agencies, multilateral, faith-based, and community organizations and the private sector in fostering "public-private partnerships" as a development platform to address urgent global health priorities.

    Dr. Steven Phillips is the Medical Director, Global Issues and Projects, Exxon Mobil Corporation, where his responsibilities include overseeing the Corporation's "outside-the-fenceline" community and public health programs throughout its global operations. In this capacity, he has worked closely with governments, NGO's, U.N. agencies, multilateral, faith-based, and community organizations and the private sector in fostering "public-private partnerships" as a development platform to address urgent global health priorities.

    Dr. Phillips currently serves on the Executive Committee and Board of Malaria NO MORE™, and the Boards of Net Impact and the World Economic Forum's Global Health Advisory Board. He serves as an advisor to the United Nations Special Envoy for Malaria. He is a member of the Harvard School of Public Health's Leadership Council and the advisory panels of Medicines for Malaria Ventures, the UCSF Global Health Group, Episcopal Relief and Development's "NetsforLife" Initiative, and the World Health Organization's Special Programme for Research and Training in Tropical Diseases (TDR) Strategic Alliances Advisory Board. Dr. Phillips received his B.S. and M.D. degrees from Stanford University. He did his post-graduate training in internal medicine at the University of California San Francisco, received a Master of Public Health from UCLA, and is Board Certified in Internal Medicine and Occupational Medicine. Dr. Phillips is a member of the American College of Physicians and a Fellow of the American College of Epidemiology. Prior to joining Exxon, Dr. Phillips served in the U.S. Public Health Service and was assigned to the Epidemic Intelligence Service of the Centers for Disease Control in Atlanta.

  • Mamphela Ramphele, MBChB, PhD

    Mamphela Ramphele, a South African national, is the Executive Chair of Circle Capital Ventures, a Cape Town based black economic empowerment company focusing on crowing companies and investing in people. 

    Mamphela Ramphele, a South African national, is the Executive Chair of Circle Capital Ventures, a Cape Town based black economic empowerment company focusing on crowing companies and investing in people. 

    She is chair of convenors of the Dinokeng Scenarios sponsored by Nedcor/Old Mutual with the report released in May 2009.  She was recently appointed as Chairperson of the Technology Innovation Agency, an entity established in the Department of Science and Technology to promote innovation culture in South Africa to enable it to turn research outputs into products and services to promote competitiveness and sustainable development. She served as Co-Chair on the Global Commission for International Migration (GCIM) between 2004-2005. She served as a Managing Director of the World Bank from May 2000 to July 2004.  As a member of the senior leadership team, she was responsible for managing the institution’s human development activities in the areas of education; health, nutrition and population; and social protection.  She was also responsible for the World Bank Institute, which provides training and learning for both staff and clients.  In addition, she provided oversight and guidance to the Bank Group’s efforts in the areas of knowledge and information and communication technologies. Prior to joining the Bank, Dr. Ramphele was Vice-Chancellor of the University of Cape Town, a post she took up in 1996, becoming the first black woman to hold this position at a South African university.  She joined the university as a research fellow in 1986, and was appointed Deputy Vice-Chancellor five years later.  She is an author of many important titles about critical socio-economic issues in South Africa.

    Dr. Ramphele has received numerous prestigious national and international awards, including numerous honorary doctorates acknowledging her scholarship, her service to the community, and her leading role in raising development issues and spearheading projects for disadvantaged persons throughout South Africa.

    Dr. Ramphele qualified as a medical doctor at the University of Natal in 1972.  She holds a PhD in Social Anthropology from the University of Cape Town, a BCom degree in Administration from the University of South Africa, and diplomas in Tropical Health and Hygiene, and Public Health, from the University of Witwatersrand.

  • Scott C. Ratzan, MD, MPA

    Dr. Scott C. Ratzan is Vice President, Global Health, Johnson & Johnson. In this role, he is charged with promoting communication, innovation and programs that focus on health literacy and public health policy. He is a pioneer in the areas of health literacy and mHealth communication, having co-authored the definition that serves as the basis for U.S. health literacy efforts. 

    Dr. Scott C. Ratzan is Vice President, Global Health, Johnson & Johnson. In this role, he is charged with promoting communication, innovation and programs that focus on health literacy and public health policy. He is a pioneer in the areas of health literacy and mHealth communication, having co-authored the definition that serves as the basis for U.S. health literacy efforts. 

    Additionally, Dr. Ratzan is the Editor-in-Chief of the peer-reviewed Journal of Health Communication: International Perspectives.  He also serves as co-chair of the United Nations Secretary General’s Every Woman Every Child Innovation Working Group and serves on the Board of Scientific Counselors, Office of Infectious Diseases, Centers for Disease Control and Prevention.  He is a member of the U.S. Institute of Medicine (IOM) Roundtable on Health Literacy, serves on the World Economic Forum Global Agenda Council on Well-Being and Mental Health, and is a former Ambassador for global health research selected by Research!America. 
    He advocates for better health in multiple ways. In 2011, he presented the industry’s “Framework for Action for the Prevention and Control of Non-Communicable Diseases” at the UN General Assembly interactive hearing.  In 2010, he was invited to testify before the US Congressional Committee on “Achieving the United Nations Millennium Development Goals: Progress through Partnerships.”    And recently, he presented at the Harvard Kennedy School Women and Public Policy Board on Global Health Diplomacy.

    Dr. Ratzan joined Johnson & Johnson in 2002 as Vice President, Government Affairs-Europe, based in Brussels with responsibility for Government Affairs and Policy issues related to pharmaceuticals in the Europe, Middle East and Africa region as well as in global health initiatives such as HIV.  Prior to joining Johnson & Johnson, he was Senior Technical Adviser in the Bureau of Global Health at the United States Agency for International Development, (USAID), where he developed the global health communication strategy for U.S. funded efforts in 65 countries.

    Dr. Ratzan maintains faculty appointments at the Columbia Mailman School of Public Health, Tufts University School of Medicine and George Washington University School of Public Health and Health Services.  Previously, he has been on faculty at the Yale School of Medicine, the University of Cambridge Judge Business School and the College of Europe. 

    He earned his MD from the University of Southern California; his MPA from the John F. Kennedy School of Government, Harvard University; and an MA in Communication from Emerson College.   

    Dr. Ratzan has appeared on Good Morning America and Nightline as well as published articles in the New York Times, Wall Street Journal and Financial Times and in academic journals. His books include the Mad Cow Crisis: Health and the Public Good, Attaining Global Health: Challenges and Opportunities, and AIDS: Effective Health Communication for the 90s. He also has delivered many presentations including the Leiter lecture on Quality Health Communication for the National Library of Medicine and an address on risk communication for the National Cancer Institute that was selected in Vital Speeches of the Day.  Dr. Ratzan also has drafted "Maxims for Effective Communication on Health and Risk Issues" that was published as part of a World Health Organization Consultation in 1998.

  • Mark Schwartz (Ex-Officio Board Member)

    Mark Schwartz is a Vice Chairman of The Goldman Sachs Group, Inc and Chairman of Goldman Sachs Asia Pacific.  He is a member of the Management Committee and is based full-time in Beijing, China.  He re-joined Goldman Sachs in June 2012 after an 11-year hiatus.  Prior to re-joining the Firm, Mark served from 2005-2012 as the Chairman and Co-Founder of MissionPoint Capital Partners, a private equity firm focused on clean energy. 

    Mark Schwartz is a Vice Chairman of The Goldman Sachs Group, Inc and Chairman of Goldman Sachs Asia Pacific.  He is a member of the Management Committee and is based full-time in Beijing, China.  He re-joined Goldman Sachs in June 2012 after an 11-year hiatus.  Prior to re-joining the Firm, Mark served from 2005-2012 as the Chairman and Co-Founder of MissionPoint Capital Partners, a private equity firm focused on clean energy. 

    Before that he served as a senior advisor, President and CEO of Soros Fund Management from 2002–2004 and as an investment banker at Goldman Sachs from 1979–2001. At Goldman in the 1990’s, Mark was the President of Goldman Sachs Japan, the Chairman of Goldman Sachs Asia and a member of the Firmwide Executive Committee. Prior to Goldman Sachs, Mark was at Harvard University where he graduated from Harvard College in 1976, Harvard Business School in 1978 and the John F. Kennedy School of Government in 1979.

    Mark and his wife Lisa are involved in many important philanthropic activities.   First and foremost, Mark is an Honorary Trustee at Massachusetts General Hospital and a Director of the President’s Council, as well as on the Board of Directors of the Ragon Institute of MGH, MIT and Harvard (formerly the Partners AIDS Research Center).  Much of Mark's focus at MGH has been devoted to global health issues with a particular focus on HIV/AIDS and tuberculosis in South Africa and Uganda.  Mark is also a Trustee of New York-Presbyterian Hospital and a member of the Executive Committee of the Hospital.  He is also a member of the Executive Committee of the Morgan Stanley Children’s Hospital of New York-Presbyterian.  Mark is also a Trustee of Northern Westchester Hospital in Mt. Kisco, NY.

    At Harvard University, Mark is a member of the Dean’s Council of Harvard College, the Dean’s Council of Harvard Medical School, the Harvard Business School’s Board of Dean’s Advisors, the Dean's Executive Committee of the Harvard Kennedy School, and is on the Advisory Boards of the Asia Center and Harvard China Fund. 

    Mark and Lisa also support land conservation efforts through the Westchester Land Trust and the Columbia Land Conservancy. Additionally, they have created and manage an organic farm called Rainbeau Ridge, which is an effort to make sustainable agriculture and land conservation an important part of the community in which they live.

    Mark is also a Director of MasterCard where he serves as Chairman of the Audit Committee, and of SoftBank Corp., a leading provider of telecom and broadband services in Japan and the US.

    Lisa (Wellesley ’77) and Mark were married in 1977, and have two children, Bari and Daniel.

  • Stephen A. Schwartz

    Steve Schwartz is the Executive Director of AO North America, a non-profit organization dedicated to supporting medical practitioners of musculoskeletal care for orthopaedic, craniomaxillofacial, spine, and veterinary patients through state-of-the-art education and research.  Prior to AO North America, Mr. Schwartz was Senior Vice President for Synthes, Inc, a highly respected medical device company, where he was employed from 1980-2012.  He is also President of GDS Consulting Services, providing expertise in the areas of medical education and medical philanthropy.

    Steve Schwartz is the Executive Director of AO North America, a non-profit organization dedicated to supporting medical practitioners of musculoskeletal care for orthopaedic, craniomaxillofacial, spine, and veterinary patients through state-of-the-art education and research.  Prior to AO North America, Mr. Schwartz was Senior Vice President for Synthes, Inc, a highly respected medical device company, where he was employed from 1980-2012.  He is also President of GDS Consulting Services, providing expertise in the areas of medical education and medical philanthropy.

    Mr. Schwartz currently sits on the Boards of several non-profit organizations dedicated to serving the medical needs of the less fortunate around the world.  These include: The Wyss Medical Foundation, Health Volunteers Overseas, and SIGN Fracture Care International.  Mr. Schwartz also works with numerous other professional societies and organizations to help support providers of patient care throughout the world. Mr. Schwartz was born and raised in Los Angeles, and is a graduate of UCLA.  He currently resides in suburban Philadelphia, where he has lived for the past 35 years.

  • Daniel J. Sullivan, Jr.

    Dan Sullivan has served as a partner and member of the management committee at Mariner Investment Group, Inc., a $9.8 billion asset management company, from 2001 to the present. Prior to his position at Mariner, Mr. Sullivan worked at Goldman, Sachs & Co. from 1977 to 1994. He held various positions with the firm and served as Partner and co-head of Goldman Sachs’ high yield business from 1988-1994.

    Dan Sullivan has served as a partner and member of the management committee at Mariner Investment Group, Inc., a $9.8 billion asset management company, from 2001 to the present. Prior to his position at Mariner, Mr. Sullivan worked at Goldman, Sachs & Co. from 1977 to 1994. He held various positions with the firm and served as Partner and co-head of Goldman Sachs’ high yield business from 1988-1994.

    Mr. Sullivan worked closely with Mark Schwartz, former Chairman of Goldman Sachs (Asia), from 1985-1991. Mr. Sullivan is a former trustee of Winsor School and BC High. He served on the Board of Regents at Georgetown University and currently serves on the Investment Committee at Columbia University. Dan earned his undergraduate degree at Georgetown and his M.B.A. at Columbia University.

  • Derek Yach, MBChB, MPH

    Dr. Yach is the Senior Vice President of The Vitality Group.  He was formerly Senior Vice President of Global Health Policy at PepsiCo where he co-led the internal Global Human Sustainability Task Force and engagement with major international policy, research and scientific groups. Previously he has headed global health at the Rockefeller Foundation, been Professor of Public Health and head of the Division of Global Health at Yale University, and is a former Executive Director of the World Health Organization (WHO).

    Dr. Yach is the Senior Vice President of The Vitality Group.  He was formerly Senior Vice President of Global Health Policy at PepsiCo where he co-led the internal Global Human Sustainability Task Force and engagement with major international policy, research and scientific groups. Previously he has headed global health at the Rockefeller Foundation, been Professor of Public Health and head of the Division of Global Health at Yale University, and is a former Executive Director of the World Health Organization (WHO).

    Dr. Yach has spearheaded several major efforts to improve global health. At the WHO he served as cabinet director under Director-General Gro Harlem Brundtland. He led development of WHO’s first treaty, the Framework Convention on Tobacco Control, and the development of the Global Strategy on Diet and Physical Activity. Dr. Yach is a South African national. He established the Centre for Epidemiological Research at the South African Medical Research Council which focused on quantifying inequalities and the impact of urbanization on health. He has authored or co-authored over 200 articles covering the breadth of global health issues. Dr Yach serves on several advisory boards including those of the Clinton Global Initiative, the World Economic Forum, the NIH’s Fogarty International Center; GAIN’s Corporate Board; the Chicago Councils’ Agricultural Development Advisory Board and Vitality USA.